Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 13, 2014Data-driven approach and implementation of BD Vacutainer® Push Button Blood Collection Sets help drive change at Robert Wood Johnson University Hospital
An article published in the Spring 2014 issue of the Journal of the Association of Occupational Health Professionals in Healthcare discusses how a systematic, data-driven approach and the...
-
May 12, 2014BD MAX™ Enteric Parasite Panel Achieves CE Mark to Detect Common and Pathogenic Intestinal ParasitesSupports comprehensive screening for infectious gastroenteritis with the BD MAX™ System
SPARKS, MD, May 12, 2014 – BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), announced today the availability of the CE-marked BD MAX™ Enteric...
-
May 8, 20142,000 sq. ft. interactive laboratory environment expansion funded by BD Diagnostics
BALTIMORE, MD, May 8, 2014 – The Maryland Science Center’s newly expanded and re-imagined space, SciLab, is now open, providing a unique, popular and hands-on laboratory science simulation for...
-
May 7, 2014Move Increases Size of Board to 10 Members
SAN DIEGO, CA, May 7, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that Supratim Bose has been elected as the 10th member of its board...
-
May 7, 2014
BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared BD MAX(TM) Enteric...
-
May 5, 2014Third quarter revenue increased 7 percent to $968 million, driven by continued growth in the company's Procedural Solutions segment
SAN DIEGO, May 5, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its third quarter of fiscal 2014, ended...
-
May 2, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Deutsche Bank 39(th) Annual Health Care Conference on...
-
May 1, 2014- Announces revenues of $2.072 billion, an increase of 3.6 percent, or 5.1 percent on a foreign currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.072 billion for the second fiscal quarter ended March 31, 2014,...
-
Apr 24, 2014Also Introduces the pink Achieve® Breast Biopsy Device
SAN DIEGO, CA, March 24, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, launched its new AVAflex ® Vertebral Balloon System today at the 39th annual Scientific...
-
Apr 24, 2014Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings
BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSPresto(TM) Near Patient CD4...